Status:
TERMINATED
IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
IMS HEALTH GmbH & Co. OHG
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
This observation plan outlines the approach to build a diabetes registry to collect data on daily routine of treatment of Type 2 Diabetes Mellitus.
Detailed Description
The choice to establish such a (general and specific) disease patient registry was based on several scientific and practical considerations as described in the AHRQ user's guide: registries for evalua...
Eligibility Criteria
Inclusion
- Provision of signed written informed consent
- Age of 18 years or older
- Diagnosis of Type 2 Diabetes Mellitus (T2DM)
Exclusion
- Only patients who don't fulfill the inclusion criteria will be excluded. There will be no further possibility for the treating physician to exclude individual patients.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
2104 Patients enrolled
Trial Details
Trial ID
NCT01906294
Start Date
August 1 2013
End Date
March 1 2016
Last Update
April 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Praxis Dr. med. Birgit Böttger
Frankfurt am Main, Germany, 60325